-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS ANNOUNCES FDA IND CLEARANCE ENABLING ACCELERATION OF PRIVOSEGTOR DEVELOPMENT PROGRAM IN ACUTE MULTIPLE SCLEROSIS RELAPSES

路透·11/16/2026 07:00:00

请登录查看新闻详情